Growth Metrics

Milestone Scientific (MLSS) Debt to Equity (2010 - 2025)

Milestone Scientific recorded quarterly Debt to Equity of $0.24 in Q2 2025, up 41.68% quarter-over-quarter from $0.17 in Q2 2013.

Milestone Scientific's Debt to Equity history runs 5 years deep, the most recent figure standing at $0.24 for Q2 2025.

  • In Q2 2025, Debt to Equity changed N/A year-over-year to $0.24; the TTM figure through Jun 2025 stood at $0.24 (changed N/A YoY), while the FY2012 annual figure was $0.23, up 0.67% from the prior year.
  • Debt to Equity came in at $0.24 for Q2 2025 at Milestone Scientific, up from $0.17 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.24 in Q2 2025 to a low of $0.24 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 0.72
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 0.04
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 0.07
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 1.02
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.30
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 1.57
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 0.45
10 Milestone Scientific 32.35 Mn 31.16 Mn 1.56 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 0.24
Jun 30, 2013 0.17
Mar 31, 2013 0.19
Dec 31, 2012 0.23
Sep 30, 2012 0.23
Jun 30, 2012 0.24
Mar 31, 2012 0.24
Dec 31, 2011 0.23
Sep 30, 2011 0.21
Jun 30, 2011 0.21
Dec 31, 2010 0.19